Zimbabwe has rejected a significant American healthcare agreement valued at $367m (£272m) spanning five years because of the United States' insistence on confidential information.
This move came to light after a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
A government spokesperson has since stated that the United States was requesting biological samples for research and profit while refused to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of winding down our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had furnished over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has called for continued talks to secure a deal acceptable to all parties so the nation's critical HIV programme can proceed.
Broader Implications
This rejection comes after a comparable case in Kenya, where a high court halted a similar health funding agreement after legal challenges were filed about the security of citizens' health data.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his administration was seeking direct bilateral deals to enhance openness and accountability.
According to statements, 16 nations in Africa have so far agreed to these new agreements, constituting over $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided immense benefits for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, without any corresponding guarantee of benefiting from any medical innovations – such as new medicines or tests – that could result from that shared data," he stated.
"In essence, our nation would supply the raw materials for medical research without any certainty that the final treatments would be available to our population if a new health crisis emerge."
National Interest and Global Health
He also pointed out that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks previously established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This system is designed to guarantee that when a nation contributes its information, the benefits – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the capability to create them."
These objections over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to further discussions with our American counterparts on how future co-operation might be arranged in a manner that honours the sovereignty and interests of each country."
Health Experts Reaction
Medical experts expressed it acknowledged the government's concerns, but recommended that talks need to persist given that much of the nation's Aids initiatives depended on external financing.
"In cases where technical issues exist, including those relating to information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," the group said.
The situation underscores the continuing tensions between receiving vital international aid and protecting national sovereignty in an ever more data-driven world.